Poison Ivy, Oak, and Sumac Rash
Poison Ivy, Oak, and Sumac Rash
References
- Poison ivy โ Health Canada, Government of Canada — Home and Garden Safety. Canada.ca
- Poisonous Plants and Work โ US Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOSH) — Outdoor Workers. CDC/NIOSH
- Poison Ivy, Oak and Sumac Contact Dermatitis โ American Family Physician (Sadovsky R, summarizing Lee NP, Arriola ER). Am Fam Physician 2000;61(11):3408
- Toxicodendron Toxicity โ StatPearls (Lofgran T, Mahabal GD); NCBI Bookshelf, National Library of Medicine. StatPearls Publishing, updated May 2023
- Death After Poison Ivy Smoke Inhalation โ American Journal of Forensic Medicine and Pathology (Woolery S, et al.). Am J Forensic Med Pathol 2022
Clinical Snapshot
Poison ivy, poison oak, and poison sumac โ collectively the genus Toxicodendron โ cause the single most common form of allergic contact dermatitis in North America, and the specific plant, allergen, and exposure counseling involved are different enough from contact dermatitis in general that this condition deserves its own chapter; see the Contact Dermatitis chapter for the general mechanism distinguishing irritant from allergic contact dermatitis, patch-testing methodology, and the topical corticosteroid potency-grading system this chapter's own pharmacologic management still relies on.
All three plants release urushiol, an oily resin found in the leaves, stems, roots, and berries, whenever any part of the plant is bruised, broken, or burned; urushiol is the sole allergen responsible for the rash, and contact with the sap โ not merely the plant itself โ is what actually triggers a reaction.[1] It is extraordinarily potent: an amount smaller than a grain of table salt is enough to cause a rash in 80-90% of exposed adults, and even a single nanogram can trigger a reaction in a sensitized person.[2][1] Roughly 50-90% of people are sensitive to urushiol on contact, depending on the population studied.[3][2]
Geographic distribution matters clinically in Canada specifically, because the three plants are not equally common here. Poison ivy is by far the most Canadian-relevant of the three โ it grows in every province except Newfoundland, on sandy, stony, or rocky shores and in thickets, clearings, and along the borders of woods and roadsides.[1] Poison oak, by contrast, is not usually found in Canada at all, apart from a western species present in southern British Columbia; it is a far more significant problem in the United States, where poisonous plant species (poison ivy, oak, and sumac combined) are found throughout the country except Alaska and Hawaii.[1][2] Poison sumac is the least commonly encountered of the three in Canada, restricted to wet-soil habitats.[1] This chapter covers plant identification, why indirect (fomite) exposure through clothing, tools, and pet fur is a genuinely important and common route of contact, the delayed-hypersensitivity timeline and its classic rash pattern, immediate post-exposure decontamination, matching treatment to severity and body site, and the red flags โ secondary bacterial infection and, specifically, inhalation of smoke from burning contaminated plant material โ that move a patient beyond routine self-care.
Recognize the Condition
Plant identification โ "leaves of three, let it be" (with an important exception)
The old rhyme is a genuinely useful mnemonic for poison ivy and poison oak, both of which typically present three leaflets per leaf, but it does not apply to poison sumac, which instead has 7 to 15 leaflets arranged along a central stem.[2][1] All three plants can occasionally present with more than the "typical" leaflet count, and their appearance varies by species, local environment, and season, so identification should never be assumed with complete confidence from a single feature alone โ when in doubt, avoid touching an unidentified plant until it has been clearly identified.[2][1]
The 3 Toxicodendron species
Poison ivy (Toxicodendron radicans and related species) โ the Canadian-relevant one
Three pointed, glossy leaflets, with the middle leaflet on a noticeably longer stalk than the two side leaflets; edges may be smooth or toothed but are rarely lobed. Leaves are reddish when they first appear in spring, turn green through summer, and become various shades of yellow, orange, or red in fall. The plant grows either as a trailing vine with upright leafy stalks 10-80 cm high, or as an aerial vine that can climb 6-10 m up trees, posts, or rough surfaces; it produces cream to yellow-green flower clusters in June-July and clustered, waxy, green-to-yellow berries by September that often persist on the bare stems through winter.[1] In the United States, eastern poison ivy is typically described as a hairy, rope-like climbing vine with three shiny leaves, while western poison ivy instead grows as a low shrub that does not climb.[2] Poison ivy is present in every Canadian province except Newfoundland, growing on sandy, stony, or rocky shores and in thickets, clearings, and along woodland and roadside borders โ by a wide margin, this is the Toxicodendron species Canadian clinicians and patients are actually likely to encounter.[1]

Poison oak โ largely a United States problem
Poison oak has the most distinctly "oak-looking" leaves of the three species, usually multi-lobed rather than smooth-edged, without aerial roots on its stems, and with fuzzy fruits and leaves.[1] It is not usually found in Canada, apart from a western species present in southern British Columbia; in the United States, Pacific poison oak can grow as a vine, with yellow or green flowers and clusters of green-yellow or white berries.[1][2] For most of the rest of Canada, poison oak can reasonably be treated as a low-probability diagnosis unless there is a specific history of recent travel to, or plant material imported from, the United States.
Poison sumac โ the rarest of the three in Canada, and the exception to "leaves of three"
Poison sumac grows specifically in wet soil conditions such as swamps and bogs, with small, sweet-smelling flowers in spring and leaves that turn vivid red and yellow in fall. Unlike poison ivy and poison oak, it never has only three leaflets โ it instead has 7 to 15 leaflets โ and it is the only one of the three species with cream-colored, rather than green-to-yellow, berries.[1] The US description is similar: a woody shrub with stems bearing 7-13 leaves arranged in pairs, and glossy, pale yellow, or cream-colored berries.[2]
The rash: timeline and the linear/streaked pattern that gives the diagnosis away
All three plants produce the same clinical picture, because it is the shared allergen โ urushiol โ that drives it, not any feature specific to one species: a Type IV, T-cell-mediated delayed hypersensitivity reaction. In an already-sensitized person, most people develop symptoms 24-48 hours after contact, though the reaction can take up to 72 hours to appear; a first-time, sensitizing exposure instead typically takes 10-14 days to produce a visible reaction, since sensitization itself has to develop before any rash can occur at all.[1][4] The extent of the reaction depends on the person's individual sensitivity and the amount of sap that actually contacted the skin.[1] Redness and intense pruritus develop first, followed by papules, vesicles, and โ in more severe reactions โ bullae, sometimes with weeping.[3] The single most useful diagnostic clue is the distribution: lesions frequently appear in linear streaks or bands that trace exactly where a brushing leaf, stem, or contaminated object touched the skin โ a pattern few other common dermatoses reproduce so faithfully.[3][4] A second, more specific pearl is "black-spot dermatitis": urushiol oxidizes and blackens on contact with air, and this oxidized residue can occasionally appear as small black, lacquer-like spots directly on the skin at the site of exposure โ when present, this finding is essentially pathognomonic for Toxicodendron exposure.[4]
New lesions commonly continue appearing for several days after the initial rash, and this is one of the most persistent sources of patient confusion and unnecessary anxiety: it does not mean the rash is spreading from lesion to lesion, and fluid from existing blisters is not sensitizing to others.[3][1] The actual explanations are far more mundane โ different body areas absorbed different amounts of urushiol and are simply reacting on their own delayed timeline, or the patient is being repeatedly re-exposed from a still-contaminated item such as clothing, tools, or a pet. Left untreated, the rash is self-limiting and typically resolves within 1-2 weeks, though it can take as long as 2-3 weeks in a more severe reaction.[3][1]

Risk Factors
- Direct contact with any bruised, broken, or burned part of a Toxicodendron plant โ leaves, stems, roots, and berries all contain urushiol, and even a plant that looks dead or dormant, including bare winter stems, can still cause a reaction.[1]
- Outdoor and occupational exposure: gardening and yard work, hiking and camping, landscaping, forestry, firefighting (including wildland firefighting), utility line clearing, construction, and agriculture all carry elevated risk given routine contact with brush and undergrowth.[2]
- Indirect (fomite) exposure โ genuinely common and often under-recognized: touching tools, gardening gloves, sports equipment, or clothing that has urushiol on it, or petting an animal whose fur picked up urushiol outdoors. No animal develops a rash from poison ivy itself, but dogs, cats, and livestock can carry active urushiol on their coats and transfer it to a person who pets or handles them.[1][2]
- Urushiol's persistence on inert surfaces is the reason indirect exposure is such a durable risk: under hot, humid conditions the sap becomes inactive in about a week, but under dry conditions it can remain active for a year or more, with up to about 5 years documented on tools and other surfaces.[1][2]
- Burning poison ivy, oak, or sumac โ whether intentionally (brush-pile or yard-waste burning) or incidentally (a wildfire or prescribed burn moving through contaminated brush) โ aerosolizes urushiol in the smoke and ash, creating a genuinely dangerous inhalational exposure route in addition to the usual cutaneous one; see Red Flags & Refer.[1][2]
- Lack of protective clothing (long sleeves, long pants, boots, gloves) during known or possible exposure, and not washing exposed clothing separately in hot, soapy water afterward.[2]
- Prior sensitization status is not fixed for life in either direction โ sensitivity can change over a person's lifetime, and a patient who reports never having reacted before can still develop a first, sensitizing reaction with future contact.
Red Flags & Refer
Most Toxicodendron dermatitis is appropriate for prompt decontamination plus standard topical (and sometimes short-course oral) self-care, but escalate for any of the following:
- Any respiratory symptom โ cough, wheeze, chest tightness, or shortness of breath โ after exposure to smoke from burning poison ivy, oak, or sumac is a medical emergency, not a minor irritation. Burning these plants releases urushiol as an aerosol that can cause severe allergic respiratory reactions and, when inhaled, deposit the allergen directly onto the lining of the airway and lungs, causing extreme pain and possibly fatal breathing problems.[1][2] This is not a theoretical risk: a 2022 case report documented two unrelated deaths from cardiopulmonary arrest following urushiol smoke inhalation.[5] Call 911 or go to the nearest emergency department immediately for any breathing difficulty, throat tightness, or facial/oropharyngeal swelling after smoke exposure, and for anyone with a history of a severe prior reaction to poisonous plants.[2]
- Signs of secondary bacterial infection โ increasing pain rather than the expected itch, spreading warmth and erythema, purulent drainage, or fever โ need evaluation and treatment for infection in addition to continued dermatitis management; see the Bacterial Skin Infections chapter.
- Widespread involvement, generally more than about 20% of body surface area, needs oral rather than only topical corticosteroid therapy.[3][4]
- Facial, periorbital, or genital involvement, especially with swelling โ get medical help promptly for a severe reaction on the face or genitals specifically, given both the functional risk (eyelid swelling threatening vision) and the degree of discomfort involved.[2]
- Classic, extensive rhus dermatitis from any of the three plants needs a full, properly tapered 2-3 week oral corticosteroid course rather than a short course โ prematurely stopping therapy risks a severe rebound flare.[3][4]
- Suspected ingestion โ if any part of a Toxicodendron plant is eaten, a real risk in young children exploring outdoors, the digestive tract, airway, kidneys, or other organs can be damaged; treat as a poisoning exposure and contact a poison control centre or seek emergency care.[1]
- No improvement, or worsening, despite an adequate and adherent trial of decontamination plus appropriately potent topical therapy โ reconsider the diagnosis, and specifically confirm that ongoing indirect exposure from contaminated clothing, tools, or pets has not been overlooked.
Assessment & Diagnosis
History
- Ask specifically about recent outdoor activity โ gardening, yard work, hiking, camping, or an outdoor occupation โ and about any contact with tools, gloves, sports or camping gear, or pets that may not have been decontaminated after their own outdoor exposure; patients very often fail to make this connection on their own, especially for a fomite-based indirect exposure.[1][2]
- Establish the timeline relative to any known or suspected exposure: 24-48 hours (up to about 72 hours) after re-exposure in an already-sensitized patient, or 10-14 days after a first, sensitizing exposure.[1][4]
- Ask directly whether the patient has been near burning brush, a bonfire, or yard-waste burning recently, particularly if there is any respiratory symptom โ this history is easy to miss unless specifically sought.[2]
Examination โ look for the linear/streaked pattern
Examine for erythema, edema, papules, vesicles, or bullae in a linear or streaked distribution tracing a plausible brushing contact, and specifically look for small black, lacquer-like spots of oxidized urushiol residue on the skin, which โ when present โ are essentially diagnostic of Toxicodendron exposure.[4] New lesions appearing over the following several days in a patient already known to have Toxicodendron dermatitis are expected and do not by themselves indicate treatment failure or true spread of the rash from lesion to lesion.[3]
Differential diagnosis
| Condition | Features that point away from Toxicodendron dermatitis |
|---|---|
| Phytophotodermatitis | Also causes streaky, linear lesions, but the mechanism is a photosensitizing plant compound (furocoumarins in limes, celery, parsnip, giant hogweed, and related plants) combined with UV light exposure, not a delayed immune reaction; look for a history of contact with one of these plants followed by sun exposure, and for a pattern that specifically corresponds to sun-exposed skin, often with striking hyperpigmentation as it resolves. |
| Cellulitis / lymphangitis | True infection produces warmth, a spreading margin, systemic symptoms (fever), and pain out of proportion to a simple dermatitis; lymphangitic streaking follows lymphatic channels toward a regional node, a different pattern than urushiol contact streaking, and needs urgent antibiotic treatment rather than a corticosteroid. |
| Insect bite reaction / papular urticaria | Typically presents as discrete, grouped papules rather than confluent linear streaks, often on exposed skin with an outdoor or camping exposure history that can otherwise mimic Toxicodendron dermatitis, especially if the patient cannot recall a specific plant contact. |
| Bullous impetigo | Flaccid, easily ruptured bullae with a honey-colored crust, typically in a young child, without the linear/streaked pattern or a plausible plant-contact history. |
| Other allergic or irritant contact dermatitis | See the Contact Dermatitis chapter for the general framework distinguishing irritant from allergic mechanisms and for patch-testing methodology when the trigger is genuinely unclear. |
Treatment Targets
- Decontaminate exposed skin, clothing, tools, and any exposed pets as promptly as possible to limit the severity of the reaction and prevent further indirect exposure to the household.
- Control acute inflammation and pruritus with appropriately potent topical, or when indicated oral, corticosteroid therapy.
- Relieve itch without introducing a second contact allergen โ avoid topical antihistamines and anesthetics directly on the rash.
- Prevent secondary bacterial infection of excoriated or weeping skin.
- Recognize and appropriately escalate widespread, facial, genital, or classic extensive rhus dermatitis to a full, correctly tapered oral corticosteroid course.
- Recognize inhalational exposure from burning contaminated plant material as a possible medical emergency, distinct from the usual cutaneous presentation.
- Counsel on plant identification, protective clothing, barrier products, and fomite decontamination to prevent both re-exposure and household spread โ the single most effective long-term intervention.
- Correct the common misconception that the rash spreads from lesion to lesion or person to person via blister fluid.
Choose Initial Treatment
Step 1 โ decontaminate immediately, before anything else
Decontamination is the single highest-yield intervention and is genuinely time-sensitive: washing thoroughly with soap and water, preferably within about 10 minutes of exposure, may prevent the dermatitis from developing at all, or meaningfully limit its severity.[3] Use cool or cold, not hot, water โ hot water opens skin pores and increases the chance that the resin is absorbed more deeply.[1] If soap is not available, a diluted vinegar solution (about 2 tablespoons per cup of water) or diluted rubbing alcohol are reasonable alternatives; rubbing alcohol, a dedicated poison-plant wash product, or plain dishwashing soap and plenty of water are all reasonable first-aid options.[1][2] Scrub under the fingernails specifically, since urushiol readily collects there and can then be transferred to other body areas or other people.[2] Rinse frequently rather than letting a wash solution dry on the skin, since a drying solution can spread urushiol to previously unaffected skin instead of removing it.[2] These measures will not reliably prevent a reaction outright once urushiol has bound to the skin โ urushiol's lipophilic nature allows genuinely rapid absorption โ but they meaningfully reduce the amount absorbed and limit spread to new areas, and remain worth doing even hours after exposure.[1][4]
Decontamination does not stop at skin: remove and launder all potentially contaminated clothing separately from other laundry, in hot, soapy water, and hang it to dry outside for several days if it cannot be washed immediately; wear gloves while handling it.[1] Clean tools, gardening gloves, and other gear with rubbing alcohol or soap and plenty of water, wearing disposable gloves while doing so, since urushiol can remain active on a contaminated surface for up to about 5 years under dry conditions.[1][2] Bathe any pet that may have been in contact with the plant โ the animal itself cannot develop a rash, but its fur can carry active urushiol back into the household.[1]
Step 2 โ topical corticosteroid, matched to body site, started early
For localized mild-to-moderate disease, once decontamination is underway, a topical corticosteroid selected by potency and body site โ using the same Canadian 7-group potency framework and body-site rules covered in the Contact Dermatitis chapter โ is first-line, and starting it early (within the first day or two, ideally before extensive vesiculation) is genuinely more effective at limiting erythema and pruritus than waiting for the rash to fully declare itself.[3] Face, eyelids, and genital skin a low-potency agent, e.g., hydrocortisone 1-2.5%. Trunk and extremities โ the most common Toxicodendron distribution a mid-potency agent, e.g., triamcinolone acetonide 0.1%, applied twice daily. Palms, soles, or severe localized disease an ultra-high-potency agent, e.g., clobetasol propionate 0.05%, limited to about 2 weeks of continuous use. Avoid occlusive dressings over moist, weeping, or vesicular lesions specifically โ occlusion increases absorption and is not appropriate for oozing Toxicodendron lesions the way it might be considered for a dry, lichenified irritant dermatitis elsewhere.[3]
Step 3 โ soothing adjuncts for oozing/vesicular lesions
Cool compresses, frequent colloidal oatmeal baths, or a diluted aluminum acetate (Burow's solution) soak are all reasonable adjuncts specifically for acute, oozing, or vesicular lesions, and calamine lotion is a widely available option for milder pruritus.[3]
Step 4 โ pruritus control, and a genuinely important thing to avoid
An oral antihistamine โ a non-sedating agent (cetirizine, loratadine, fexofenadine) during the day, or a sedating agent (diphenhydramine, hydroxyzine) at bedtime specifically when itching disrupts sleep โ is a reasonable adjunct for comfort, though the underlying process is T-cell-, not histamine-, mediated, so an antihistamine alone does not substitute for decontamination and an appropriately potent topical corticosteroid. Do not use a topical antihistamine or topical anesthetic โ for example, a topical diphenhydramine or benzocaine preparation โ directly on the rash: these carry a genuine, well-recognized risk of independently sensitizing the skin to a second allergen layered on top of the existing urushiol reaction, and an oral antihistamine is the safer route to the same symptom relief.[3]
Step 5 โ oral corticosteroid for widespread, facial/genital, or extensive rhus dermatitis
Widespread disease (more than about 20% of body surface area), significant facial or genital involvement, or classic, extensive rhus dermatitis from any of the three plants a properly dosed and tapered oral prednisone course: approximately 1 mg/kg/day (0.5 mg/kg/day in pediatric patients), to a maximum of 60 mg/day, tapered gradually โ weekly step-downs are one reasonable approach โ over a full 2-3 weeks.[4][3] Do not use a standard prepackaged short oral corticosteroid "dose pack," and do not stop an oral course abruptly once started โ as covered in the Contact Dermatitis chapter, both practices are well-recognized causes of a genuine, sometimes severe, rebound flare, and rhus dermatitis is specifically the disease this caution was originally written about.[3][4]
Step 6 โ treat secondary bacterial infection if present
Staphylococcus aureus is the most commonly implicated organism in secondary bacterial infection of excoriated or weeping Toxicodendron lesions.[4] A macerated, weeping, or frankly infected area needs an appropriate oral or topical antibiotic in addition to continued dermatitis management; see the Bacterial Skin Infections chapter for specific antibiotic selection.
Step 7 โ prevention for known future exposure
For patients with predictable future exposure, occupational or recreational, a barrier skin cream containing bentoquatam (an organoclay preparation) can offer some protection when applied before anticipated contact, reapplied roughly every 4 hours during prolonged exposure and washed off and reapplied per product directions; combined with protective clothing (long sleeves, long pants, boots, gloves), this is genuinely the most effective way to prevent the reaction from occurring at all, rather than only treating it after the fact.[2][3]
Non-Pharmacologic Treatment
- Wash exposed skin with cool or cold water and soap (or a vinegar/alcohol alternative) as soon as possible after known or suspected exposure, ideally within about 10 minutes; rinse frequently rather than letting a wash solution dry on the skin.[3][1][2]
- Remove and separately launder any potentially contaminated clothing in hot, soapy water, and clean tools and gear with rubbing alcohol or soap and water, wearing gloves throughout, since active urushiol can persist on surfaces for a long time โ up to about a week under hot/humid conditions, or up to a year or more, occasionally cited as long as 5 years, under dry conditions.[1][2]
- Bathe pets that may have been outdoors in a possible exposure area; the animal itself will not develop a rash, but its fur can carry active urushiol to household members.[1]
- Use cool compresses, frequent colloidal oatmeal baths, or a diluted aluminum acetate (Burow's solution) soak for acute, oozing, or vesicular lesions.[3]
- Avoid hot showers or baths while the rash is active โ heat tends to worsen itch and can further open pores.[1]
- Discourage scratching; trim nails short, since urushiol can also collect under nails after direct plant contact and be transferred elsewhere.[2]
- Counsel explicitly that the rash does not spread from lesion to lesion or from person to person through blister fluid โ apparent new areas usually reflect staggered absorption at different body sites, or ongoing contact with a still-contaminated item, not contagion.[3][1]
- Learn to identify poison ivy, oak, and sumac, and wear long sleeves, long pants, boots, and gloves for outdoor activities or occupations with a known exposure risk; consider a bentoquatam barrier cream before anticipated exposure.[2]
- Never burn poison ivy, oak, or sumac. Burning releases urushiol into the air as fine droplets carried on ash and smoke particles, and a severe, even fatal, reaction can follow if a sensitive person inhales or is otherwise exposed to that smoke; dispose of pulled or dead plant material by sealing it in a garbage bag rather than burning it, since even a dead plant remains capable of causing a reaction.[1]
Pharmacologic Treatment Options
| Drug / intervention | Role | Dose / use | Important adverse effects | Teaching points |
|---|---|---|---|---|
| Hydrocortisone 1-2.5% (topical) Preferred | Low potency โ 1st line, face, eyelids, and genital skin, and for early mild disease | Apply BID-TID | Local burning/stinging; atrophy uncommon at this potency | Start as early as possible, ideally within the first day or two, to limit erythema and pruritus rather than waiting for the rash to fully declare itself. |
| Triamcinolone acetonide 0.1% (topical) Preferred | Mid potency โ 1st line, trunk/limbs, the most common Toxicodendron distribution | Apply BID | Local burning/stinging; atrophy/striae with prolonged use | Avoid occlusive dressings over moist or weeping vesicular lesions specifically. |
| Clobetasol propionate 0.05% (topical) Special situation | Ultra-high potency โ palms/soles or severe localized disease | Apply once or twice daily, maximum about 50 g/week, for up to 2 weeks | Skin atrophy, striae, telangiectasia; rare HPA-axis suppression with extensive/prolonged use | Avoid occlusive dressings at this potency; step down to a lower-potency agent once controlled. |
| Cetirizine Preferred | Oral antihistamine, daytime pruritus, non-sedating | 10 mg PO once daily | Mild sedation, headache | Adjunct for comfort only โ does not replace decontamination or an appropriately potent topical corticosteroid; oral antihistamines are the safer route to itch relief than a topical one. |
| Diphenhydramine (oral) Alternative | Oral antihistamine, bedtime specifically if itching disrupts sleep | 25-50 mg PO at bedtime PRN | Sedation, anticholinergic effects, next-day grogginess | Oral use only โ do not apply a topical diphenhydramine product to the rash, given a genuine risk of additional contact sensitization. |
| Prednisone (oral) Special situation | Widespread (over 20% BSA), facial/genital, or classic extensive rhus (poison ivy/oak/sumac) dermatitis | Approximately 1 mg/kg/day (0.5 mg/kg/day pediatric), maximum 60 mg/day, tapered gradually over 2-3 weeks | Insomnia, mood changes, increased appetite, hyperglycemia; adrenal suppression/rebound with an inadequate course | Do not use a prepackaged short "steroid dose pack" and do not stop the course abruptly โ rhus dermatitis is specifically the disease the rebound-flare caution was written about. |
| Cephalexin Special situation | Secondary bacterial infection of excoriated/weeping lesions (commonly Staphylococcus aureus) | 250-500 mg PO QID (adult); weight-based pediatric dosing | GI upset, hypersensitivity reactions | Reserve for genuine signs of secondary infection โ spreading warmth/erythema, purulent drainage, fever โ not routine dermatitis. |
Special Populations
Pregnancy
Decontamination washing is safe and recommended in pregnancy exactly as for any other patient โ there is no reason to delay it. Low-to-mid potency topical corticosteroids are preferred given minimal systemic absorption at recommended use; reserve high- and ultra-high-potency agents, and large-surface-area use of any potency, for genuine need. Non-sedating oral antihistamines (loratadine, cetirizine) are generally preferred if an oral agent is needed. A short course of oral prednisone is reasonable for severe, widespread disease when the benefit outweighs the risk, decided together with the prescriber. If a pregnant patient's own yard or garden needs poison ivy removed, herbicide application and direct handling of the plant are both reasonable tasks to delegate to someone else rather than to perform personally.
Breastfeeding
Topical corticosteroids at any potency are compatible with breastfeeding; wash the area before the next feed if applying near the breast or nipple. Non-sedating oral antihistamines are preferred over sedating agents. A short oral prednisone course is also compatible with breastfeeding.
Pediatrics
Children explore outdoor environments hands-first and are both more likely to have direct plant contact and more likely to pick up indirect exposure from a family pet after it has been outdoors. Ingestion is a genuine risk specifically in young children and can damage the digestive tract, airway, kidneys, or other organs โ treat any witnessed or suspected ingestion as a poisoning exposure.[1] If a child has handled a parent's or caregiver's contaminated outdoor work clothing, contact a pediatrician even before an obvious rash has appeared, given the delayed timeline.[2] Dose topical corticosteroids and antihistamines by weight per the current product monograph, and favour the lowest effective corticosteroid potency given children's higher body-surface-area-to-weight ratio and thinner skin.
Older adults
Skin thins with age, increasing both topical corticosteroid absorption and the visible impact of atrophy and purpura โ use the lowest effective potency and monitor closely. Avoid sedating 1st-generation antihistamines (diphenhydramine, hydroxyzine) where possible, given anticholinergic burden and fall risk.
Outdoor and occupational workers
Landscapers, gardeners, foresters, firefighters (including wildland firefighters), utility line workers, and agricultural workers carry the highest occupational exposure risk.[2] Employers should train workers to identify the three plants, understand their own exposure risk, and know both prevention measures and what to do after exposure.[2] When burning contaminated plant material cannot be avoided in an occupational setting, workers need a NIOSH-certified half-face-piece particulate respirator rated at least R-95 or P-95 โ firefighters specifically may need a higher level of respiratory protection given exposure to broader combustion products โ worn correctly and consistently with a proper face seal, under a written respiratory protection program.[2]
Darker skin tones
Postinflammatory hyperpigmentation is common after Toxicodendron dermatitis resolves and can persist for months โ counsel on this expected course so it is not mistaken for treatment failure or an ongoing active reaction.
Monitoring & Follow-Up
Set realistic expectations from the outset: an uncomplicated reaction typically resolves within about 1-2 weeks, though a more severe reaction can take 2-3 weeks even with appropriate treatment.[3][1] New lesions appearing over the first several days after the initial rash are expected and do not by themselves mean treatment has failed.
Treatment Failure / Next Step
- Confirm decontamination was actually completed โ exposed skin washed promptly, and contaminated clothing, tools, and any exposed pets genuinely decontaminated โ since continued unrecognized indirect exposure is the single most common cause of apparent treatment failure.
- Confirm adherence and correct application technique for the topical corticosteroid before assuming the agent itself has failed.
- Reconsider the diagnosis โ phytophotodermatitis, cellulitis/lymphangitis, an insect-bite reaction, or another dermatitis can all mimic a Toxicodendron presentation; see Assessment & Diagnosis.
- Confirm a topical antihistamine or anesthetic has not been applied directly to the rash, which can itself cause a second, superimposed contact dermatitis and delay resolution.
- If diagnosis, decontamination, and adherence are all confirmed and the response is still inadequate, step up topical potency within the site-appropriate ceiling, or escalate to a properly dosed and tapered oral corticosteroid course if criteria are met.
- Refer to dermatology or allergy for recurrent or unusually severe reactions, diagnostic uncertainty despite the above, or a patient interested in confirmatory patch testing.
Common Errors to Avoid
- Washing with hot rather than cool/cold water after known or suspected exposure โ hot water opens pores and can increase absorption of the resin.
- Delaying decontamination โ the highest-yield window for reducing severity is genuinely early, within roughly the first 10 minutes to hour after exposure.
- Applying a topical antihistamine or topical anesthetic โ for example, topical diphenhydramine or benzocaine โ directly to the rash, given a real risk of independently sensitizing the skin to a second allergen on top of the existing reaction.
- Treating only the skin and not the fomites โ failing to decontaminate contaminated clothing, tools, and pets predictably leads to repeated indirect re-exposure and an apparent "treatment failure" that is really ongoing contact.
- Prescribing a standard prepackaged oral corticosteroid "dose pack," or allowing a patient to stop an oral course early once symptoms improve โ both risk a genuine, sometimes severe, rebound flare in rhus dermatitis specifically.
- Missing a smoke-inhalation history in a patient with new respiratory symptoms during brush-clearing, bonfire, or yard-waste-burning season โ treat any respiratory symptom after burning-plant exposure as a possible emergency, not an incidental cough.
- Allowing a patient to believe the rash is contagious via blister fluid or by touching another person, which causes unnecessary anxiety and, occasionally, inappropriate self-isolation.
- Using an occlusive dressing over a moist, weeping, or vesicular lesion.
- Missing early secondary bacterial infection and continuing to treat spreading warmth, increasing pain, or purulent drainage as "just a flare."
Clinical Decision Algorithm
Drug Tables
How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.
Pre-Exposure Prevention (Barrier Product)
For predictable future exposure only โ this is a prevention product, not a treatment for an established rash. Combine with protective clothing (long sleeves, long pants, boots, gloves) for the most effective prevention.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Bentoquatam (organoclay barrier cream) | Dosing: Apply at least 15 minutes before anticipated exposure; reapply approximately every 4 hours during prolonged exposure | Local dryness or irritation | None significant | No Pharmasist Drug Database monograph currently exists for this product (brand name IvyBlock); named as text only. Apply before anticipated contact; wash off and reapply per product directions. |
Topical Corticosteroids, by Potency
Use the lowest potency that controls the reaction; match potency to body site as in the Contact Dermatitis chapter (low potency for face/eyelids/genital skin, higher potency for palms/soles/resistant disease). Start as early as possible after decontamination, and avoid occlusive dressings over moist, weeping, or vesicular lesions.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Hydrocortisone 1-2.5%, topical | Dosing: Apply BID-TID | Local burning/stinging; atrophy uncommon at this potency | None clinically significant given minimal systemic absorption | Low potency. 1st-line agent for the face, eyelids, and genital skin, and for early mild disease elsewhere. |
| Desonide, topical 0.05% | Dosing: Apply BID | Local burning/stinging; atrophy and striae uncommon at this potency | None clinically significant given minimal systemic absorption | Low-mid potency. A reasonable alternative to hydrocortisone for sensitive sites, including in young children. |
| Triamcinolone acetonide 0.1%, topical | Dosing: Apply BID | Striae, telangiectasia, atrophy, purpura with prolonged use | None clinically significant given minimal systemic absorption | Mid potency. Reasonable default for trunk/limb involvement, the most common Toxicodendron distribution. |
| Betamethasone dipropionate 0.05%, topical | Dosing: Apply BID | Striae, telangiectasia, atrophy, purpura; HPA-axis suppression with extensive/prolonged use | None clinically significant at recommended topical doses | High potency. Resistant or thicker plaques on the trunk/limbs only โ not for the face or genital skin. |
| Clobetasol propionate 0.05%, topical | Dosing: Apply once or twice daily, maximum 2 weeks | Skin atrophy, striae, telangiectasia; systemic absorption possible with extensive-area or occlusive use | None clinically significant with topical use at recommended doses | Ultra-high potency. Palms, soles, or severe localized disease; limit to about 50 g/week and 2 weeks continuous use, and avoid occlusion. |
Oral Antihistamines โ Pruritus Adjunct
Symptom relief only; the itch of Toxicodendron dermatitis is T-cell-, not histamine-, mediated, so an antihistamine does not substitute for decontamination and an appropriately potent topical corticosteroid. Use the oral route only โ topical antihistamines and topical anesthetics (e.g., topical diphenhydramine, benzocaine) should be avoided directly on the rash, given a genuine risk of independently sensitizing the skin to a second allergen.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Cetirizine | Adults: 10 mg PO once daily | Mild sedation (dose-related), headache, dry mouth | Additive CNS depression with alcohol or other sedatives | Non-sedating; a metabolite of hydroxyzine โ avoid in patients with hydroxyzine hypersensitivity. |
| Loratadine | Adults: 10 mg PO once daily | Headache, fatigue, dry mouth | Clearance decreased in severe hepatic impairment โ use a lower initial dose | Non-sedating alternative to cetirizine; also a reasonable choice in pregnancy and breastfeeding. |
| Fexofenadine | Adults: 60 mg PO BID, or 180 mg PO once daily | Headache, nausea | Aluminum- or magnesium-containing antacids and fruit juices can decrease bioavailability | Non-sedating; renal impairment increases the risk of CNS accumulation. |
| Diphenhydramine, oral | Adults: 25-50 mg PO at bedtime PRN | Sedation, anticholinergic effects, next-day grogginess | Additive CNS depression with alcohol/sedatives; may increase levels of some CYP2D6 substrates | Reserve for bedtime use when itching disrupts sleep; use caution in older adults given anticholinergic burden and fall risk. Oral use only โ see class note above. |
| Hydroxyzine | Adults: 25-50 mg PO at bedtime PRN | Sedation, dry mouth, blurred vision, dizziness | Additive CNS depression with alcohol, opioids, or other sedatives | Alternative sedating agent to diphenhydramine; same bedtime-only rationale and older-adult caution. |
Oral Corticosteroid โ Widespread or Severe Disease
Reserve for widespread disease (over about 20% body surface area), significant facial/genital involvement, or classic, extensive rhus (poison ivy/oak/sumac) dermatitis. Never substitute a prepackaged short "steroid dose pack" and never stop the course abruptly โ rhus dermatitis is specifically the disease the rebound-flare caution was written about.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Prednisone, oral | Standard course: Approximately 1 mg/kg/day PO (0.5 mg/kg/day pediatric), maximum 60 mg/day Taper: Gradually over a full 2-3 weeks โ weekly step-downs are one reasonable approach | Insomnia, mood changes, increased appetite, hyperglycemia; adrenal suppression and rebound dermatitis with an inadequate course or abrupt discontinuation | Numerous โ review the full interaction profile even for a short course | No plain oral prednisone tablet monograph currently exists in the Pharmasist Drug Database; named as text only. |
Topical Adjuncts (Non-Corticosteroid)
Symptomatic and soothing measures used alongside, not instead of, decontamination and an appropriately potent topical corticosteroid when one is indicated.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Calamine lotion | Dosing: Apply to affected areas as needed | Local dryness | None significant | Widely available OTC option with a long safety record for mild pruritus; no Pharmasist Drug Database monograph exists for this product. |
| Colloidal oatmeal bath | Dosing: Add to a lukewarm (not hot) bath per product directions; soak 15-20 minutes | Local dryness with overuse | None significant | Frequent baths using colloidal oatmeal relieve symptoms in acute/vesicular disease; no Pharmasist Drug Database monograph exists for this product. |
| Aluminum acetate solution (Burow's solution) | Dosing: Dilute per product directions; soak or compress 15-30 minutes, 2-3 times daily | Local dryness with overuse | None significant | Astringent cool-soak solution for acute, oozing, or vesicular lesions; no Pharmasist Drug Database monograph exists for this product. |
Secondary Bacterial Infection
Reserve for genuine signs of secondary infection โ spreading warmth/erythema, purulent drainage, or fever, most commonly caused by Staphylococcus aureus โ not routine dermatitis; see the Bacterial Skin Infections chapter for full antibiotic selection.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Cephalexin | Adults: 250-500 mg PO QID Children: Weight-based pediatric dosing per the current product monograph | GI upset, hypersensitivity reactions | May increase INR with warfarin | Reasonable oral option for uncomplicated secondary bacterial infection of excoriated or weeping skin. |
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.